Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial

Overview of attention for article published in Prostaglandins, Leukotrienes and Essential Fatty Acids, March 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

FADS2 Indel polymorphism rs66698963 predicts colorectal polyp prevention by the n-3 fatty acid EPA

Preprint in medRxiv (October 2023)

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial

Article in International Journal of Cancer (October 2023)

Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short‐term aspirin use

Article in Alimentary Pharmacology & Therapeutics (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.